Retatrutide — 40mg
Product Overview
Retatrutide, also identified in research as LY3437943, is a synthetic single-peptide agonist designed to engage glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1) and glucagon receptors.
Research Background
The compound provides a model for studying how three related receptor systems can be activated by one engineered ligand. These receptors are coupled to overlapping but distinct signalling networks, making retatrutide useful in receptor-potency, pathway-bias and integrated metabolic-signalling research.
Current Areas of Investigation
Published research includes recombinant receptor assays, cell-based cyclic-AMP studies, animal models and regulated clinical trials. Investigators examine receptor balance, downstream endocrine signalling and how multi-receptor pharmacology differs from selective GLP-1 or dual GIP/GLP-1 agonism.
In Plain Language
Researchers are studying whether activating three related hormone receptors together can influence appetite, blood-sugar regulation, energy use and body-weight-related metabolic pathways differently than targeting only one receptor. GIP and GLP-1 signalling are connected with nutrient response and fullness, while glucagon-receptor signalling adds another pathway involved in glucose and energy metabolism.
In plain terms, retatrutide research explores whether coordinating all three signals may produce broader metabolic changes than a single- or dual-receptor compound. Published trials have reported changes in food intake, body weight and glucose measures, while laboratory work continues to examine which receptor contributes to each observation.
Product Specifications
- Catalogue No.: RT
- Vial Size: 40mg
Quality & Documentation
Lot-specific product documentation and Certificate of Analysis (COA) information may be available through AURAPEP where applicable.
Research Use Only
RESEARCH USE ONLY — NOT FOR HUMAN CONSUMPTION. Supplied strictly for laboratory, analytical and research purposes. Not intended for self-administration or to diagnose, treat, cure or prevent any disease.
